The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrom;Wpływ 3-tygodniowego leczenia za pomoca̧ cia̧gł ego dodatniego ciśnienia w drogach oddechowych na stȩżenie leptyny i homocysteiny w surowicy u chorych z obturacyjnym bezdechem podczas snu

Pneumonologia i Alergologia Polska

Volumn 74, Issue 1, 2006, Pages 63-67

  Rubinsztajn, Renata ^a   Kumor, Marta ^a   Byśkiniewicz, Krzysztof ^a   Chazan, Ryszarda ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Homocysteine; Leptin; nCPAP; OSA

Indexed keywords

FIBRINOGEN; HOMOCYSTEINE; LEPTIN; BIOLOGICAL MARKER;

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; HEALTH CARE; HUMAN; HYPERTENSION; MALE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; RISK ASSESSMENT; RISK FACTOR; SLEEP APNEA SYNDROME; SLEEP DISORDER; BLOOD; MIDDLE AGED; PATHOPHYSIOLOGY;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HOMOCYSTEINE; HUMANS; LEPTIN; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 33745747410     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Barcelo A., Barbé F., Liompart E.i wsp.: Neuropeptide Y and Leptin in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med, 2005, 17, 183-187
2. Byśkiniewicz K.: Obturacyjny bezdech podczas snu (w) Pneumonologia i alergologia praktyczna- wybrane jednostki chorobowe, Chazan R. (red) á-medica press 2001, 52
3. Can M., Acikgoz S., Mungan G. i wsp.: Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006, 129, 233-237
4. Daniluk U., Karczmarski M., Wasilewska J. i wsp.: Fizjologiczne i patologiczne mechanizmy reguluja̧ce lłlaknieniem czlowieka. Terapia 2002,2,
5. Grunstein R, Wilcox I, Young T. i wsp.: Snoring and sleep apnea in men: association with central obesity and hypertension: Int J Obes Relat Metab Disord.1993, 17, 533-540
6. Harsch I., Konturek P., Koebnick C. i wsp: Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect on CPAP treatment. Eur Respir J 2003, 22, 251-257
7. Houseknecht K., Baile C., Matteri R. i wsp.: The biology of leptin: a review. J Anim Sci. 1998, 76, 1405-1420
8. Ip M., Lam K., Ho Ch i wsp.: Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000, 118, 580-6
9. Jordan W., Beger C., Cohrs S i wsp: CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J. Neural Transm, 2004, 111, 683-689
10. Lavie P. i wsp. All-cause mortality in males with sleep apnea syndrome declining mortality rates with age Eur. Resp. J 2005, 25:514-520
11. Lavie L., Perelman A., Lavie P: Plasma homocysteine levels in obstructive sleep apnea. Chest 2001, 120, 900-908
12. Leung R.S.T., Bradley D,T. "Sleep Apnea and cardiovascular disease. State of the Art." Am J Respir Crit Care Med 2001; 164: 2147-2165
13. Levinson P, McGarvey S., Carlisle C.i wsp: Adiposity and cardiovascular risk factors in men with obstructive sleep apnea.Chest 1993, 103, 1336-1342
14. Mart S.i wsp. Mortality in severe sleep apnoea/hypopnoea syndrome patients:impact of treatment, Eur.Resp. J 2002;20:15111-1518
15. Mary S M, Bing Lam, Lai-Yee Chan i wsp "Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continous positive airway pressure Am J Respir Crit Care Med 2000; 162: 2166-2171
16. Am J Respir Crit Care Med 1993; 91: 308-318
17. Philips B., Hisel T., Kato M I wsp. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 1999, 17, 1297-1300
18. Phillips B., Kato M., Narkiewicz K i wsp. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J. Physiol Heart Circ Physiol 2000, 279, H234-H237
19. Pływaczewski R. Czȩstość i nasilenie zaburzeń oddychania w czasie snu wśród dorosiych mieszkancow prawobrzeżnej Warszawy. Biblioteka rozpraw habilitacyjnych Instytutu Gruźlicy i Chorob Phic. Tom 8. Warszawa 2003.
20. Reaven G. Role of insulin resistance in human disease. Diabetes 1988, 37, 1595-1607
21. Robinson G. Pepperell J., Segal H. i wsp.: Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomized controlled trials. Thorax 2004, 59, 777-782
22. Rubinsztajn R. Kumor M., Byskiniewicz K. i wsp. Stȩżenie leptyny w surowicy i aktywność układu adrenergicznego oceniana na podstawie stȩżenia adrenaliny i noradrenaliny w surowicy u chorych na obturacyjny bezdech podczas snu. Pol Arch Med Wewn 2005, 113, 544-551
23. Sanner B., Kollhosser P., Buechner N., M. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur. Respir. J, 2004, 23, 601-604
24. Somers V., Myken M., Clary M. i wsp.: Sympathetic neural mechanism in obstructive sleep apnea. J. Clin Invest. 1995, 96, 1897-1904
25. Stamler J.S., Osborne J.A., Jaraki O. i wsp. Adverse vascular effects of homocysteine are modulated by endothelium - derived relaxing factor and related oxides of nitrogen" 1993, 91, 308-318.
26. Svatikova A., WoIk R., Magera M. i wsp.: Plasma homocysteine in obstructive sleep apnoea. Europ. Heart J. 2004, 25, 1325-1329
27. Trzebski A. Aktywnosc ukladu współczulnego w neurogennym nadcisnieniu tȩtniczym i jej modulacja przez odruch z baroreceptorow i chemoreceptorów w: Nadciśnienie neurogenne E.Szczepańska- Sadowska. A. Trzebski, W Januszewicz, A. Januszewicz (red) Wyd Naukowe PWN Warszawa 1998,str102-104
28. Woutears M, Mertens I., Considine R i wsp.: Are leptin levels dependent on body fat distribution in obese men and women. Eat Weight Disord 1998, 3, 124-130
29. Wielo F., Young T., Lind B. I wsp.: Association of sleep disordered breathing, sleep apnea and hypertension in large community-based study. Sleep Heart Health Study, JAMA 200, 283, 1829-1836
30. Wilcox I, McNamara S., Collins F i wsp.: "Syndrome Z": the interaction of sleep apnea, vascular risk factors and heart disease. Thorax 1998, 53( suppl 3), S25-S28
31. Young T., Palta J., Dempsey J i wsp.: The occurrence of sleep - disordered breathing among middle-aged adults. N. Engl. J. Med. 1993, 328, 1230
32. Young T., Peppard P., Palta M. i wsp. Population-based study of sleep disordered breathing as a risk factor for hypertension. Arch. Inter. Med. 1997, 157, 1746-1752